[
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Retreat Late Afternoon",
    "summary": "Health care stocks declined late Tuesday afternoon, with the NYSE Health Care Index falling 1.6% and",
    "url": "https://finnhub.io/api/news?id=36390b5a941276368cc94bd125809c11000b72c05969ba90011147e0800e78d7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765918802,
      "headline": "Sector Update: Health Care Stocks Retreat Late Afternoon",
      "id": 137806230,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Health care stocks declined late Tuesday afternoon, with the NYSE Health Care Index falling 1.6% and",
      "url": "https://finnhub.io/api/news?id=36390b5a941276368cc94bd125809c11000b72c05969ba90011147e0800e78d7"
    }
  },
  {
    "ts": null,
    "headline": "PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors",
    "summary": "Appointment Enhances PolyPid’s Strategic, Commercial and Transaction Capabilities Ahead of D-PLEX₁₀₀ New Drug Application SubmissionPETACH TIKVA, Israel, Dec. 16, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced the appointment of Brooke Story as Chairman of the Board of Directors, effective as of December 11, 2025. “Brooke’s appointment marks an exciting and pivotal moment for P",
    "url": "https://finnhub.io/api/news?id=9151c2dd5d5d9bba108cc7b97ffdf8c0516a7adbb5aaa05462336e4bc46fc7ed",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765891800,
      "headline": "PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors",
      "id": 137806455,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Appointment Enhances PolyPid’s Strategic, Commercial and Transaction Capabilities Ahead of D-PLEX₁₀₀ New Drug Application SubmissionPETACH TIKVA, Israel, Dec. 16, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced the appointment of Brooke Story as Chairman of the Board of Directors, effective as of December 11, 2025. “Brooke’s appointment marks an exciting and pivotal moment for P",
      "url": "https://finnhub.io/api/news?id=9151c2dd5d5d9bba108cc7b97ffdf8c0516a7adbb5aaa05462336e4bc46fc7ed"
    }
  }
]